These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26204275)

  • 41. Inconsistencies in findings from the early lung cancer action project studies of lung cancer screening.
    Bach PB
    J Natl Cancer Inst; 2011 Jul; 103(13):1002-6. PubMed ID: 21685356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung cancer screening: advantages, controversies, and applications.
    Nanavaty P; Alvarez MS; Alberts WM
    Cancer Control; 2014 Jan; 21(1):9-14. PubMed ID: 24357736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    Katki HA; Prorok PC; Castle PE; Minasian LM; Pinsky PF
    J Natl Cancer Inst; 2024 Aug; 116(8):1280-1287. PubMed ID: 38603624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    Katki HA; Prorok PC; Castle PE; Minasian LM; Pinsky PF
    J Natl Cancer Inst; 2024 Oct; 116(10):1675-1682. PubMed ID: 39267581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline characteristics of participants in the randomized national lung screening trial.
    ; Aberle DR; Adams AM; Berg CD; Clapp JD; Clingan KL; Gareen IF; Lynch DA; Marcus PM; Pinsky PF
    J Natl Cancer Inst; 2010 Dec; 102(23):1771-9. PubMed ID: 21119104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
    O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
    PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
    Murugan VA; Kalra MK; Rehani M; Digumarthy SR
    J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lung cancer screening: where have we been? Where are we going?
    Carlile PV
    J Okla State Med Assoc; 2015 Jan; 108(1):14-8. PubMed ID: 25790581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lung cancer screening with thoracic X‑ray and CT : Current situation].
    von Stackelberg O; Kauczor HU
    Radiologe; 2016 Sep; 56(9):793-7. PubMed ID: 27411917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Annual number of lung cancer deaths potentially avertable by screening in the United States.
    Ma J; Ward EM; Smith R; Jemal A
    Cancer; 2013 Apr; 119(7):1381-5. PubMed ID: 23440730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for lung cancer.
    Prosch H; Schaefer-Prokop C
    Curr Opin Oncol; 2014 Mar; 26(2):131-7. PubMed ID: 24441507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Oken MM; Marcus PM; Hu P; Beck TM; Hocking W; Kvale PA; Cordes J; Riley TL; Winslow SD; Peace S; Levin DL; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Dec; 97(24):1832-9. PubMed ID: 16368945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening.
    Curl PK; Kahn JG; Ordovas KG; Elicker BM; Naeger DM
    AJR Am J Roentgenol; 2015 Aug; 205(2):344-7. PubMed ID: 26204285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Lung cancer screening among the smoker population].
    Coureau G; Delva F
    Bull Cancer; 2019; 106(7-8):693-702. PubMed ID: 30777302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung cancer screening has the potential to safe lives, but shall we do it?
    Russi E
    Swiss Med Wkly; 2011; 141():w13185. PubMed ID: 21491209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for lung cancer: time for large-scale screening by chest computed tomography.
    Shlomi D; Ben-Avi R; Balmor GR; Onn A; Peled N
    Eur Respir J; 2014 Jul; 44(1):217-38. PubMed ID: 24525442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Tammemagi MC; Commins J; Oken MM; Kvale PA; Hu P; Ragard LR; Riley TL; Pinsky P; Beck TM; Prorok PC
    Lung Cancer; 2013 Nov; 82(2):238-44. PubMed ID: 23993734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.